13 Nov

HealthBeacon appoints Sean Glynn as first Director of HEOR, and Dr. Zara Fullerton Kinsella as first Medical Science Liaison

HealthBeacon appoints first Director of HEOR and hires first Medical Science Liaison.

(Dublin, Ireland; Boston, MA, – November 13th, 2019) Leading medication adherence technology company, HealthBeacon has announced the appointments of Sean Glynn as Director of Health Economics and Outcomes Research, and Dr. Zara Fullerton Kinsella as Medical Science Liaison.

Sean Glynn, Director of HEOR, joined the HealthBeacon team three years ago with the critical role of launching HealthBeacon’s operations in the US. Sean’s background in behavioral sciences and his deep understanding of the medication adherence issue will be instrumental in furthering HealthBeacon’s mission to improve patient outcomes by delivering new adherence solutions to patient’s who self-administer injectable medications in their homes. Sean is based out of HealthBeacon’s Boston office.

Dr. Zara Fullerton Kinsella has joined the HealthBeacon team as a Medical Science Liaison, to facilitate clinical research and assist with Regulatory Affairs. Zara is a medical doctor with an undergraduate degree in Business and Economics at Trinity College. Her keen interest in healthcare led her to study Graduate Entry Medicine at University College Cork. As a junior doctor, she worked in a variety of medical specialties. Zara is based out of HealthBeacon’s office in Dublin, Ireland.

These appointments will further HealthBeacon’s commitment to evidence-based decision making and program design. “We are excited to expand our team and add these critical capabilities with Sean being promoted to Director of HEOR and Dr. Zara joining the team as our Medical Science Liaison” said Jim Joyce, CEO of HealthBeacon, “these roles will bring through our latest studies, data projects and provide important medical insights into product development.”

About HealthBeacon

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy. The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow. This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of
80-90%.

 

HealthBeacon’s Medical Science Liaison Dr. Zara Fullerton Kinsella

HealthBeacon’s HEOR Sean Glynn

Media Enquiries: Mary Principe  | Email: events@healthbeacon.com